AiCure (H. Code)

by AiCure  · Based in United States → — Pioneers in Verified Medical Adherence Proven Outcomes. Real-world Evidence.
Internal Medicine Oncology Psychiatry

Regulatory Status Disclosed

Overview

AiCure’s H.Code platform is an advanced AI-powered adherence verification solution designed for pharmaceutical companies, Contract Research Organizations (CROs), and healthcare providers. It leverages cutting-edge computer vision, synchronous chat, and predictive analytics to meticulously monitor and enhance medication and clinical behavior adherence across the entire healthcare lifecycle.

For physicians involved in clinical research, H.Code revolutionizes participant engagement by observing and assisting trial participants directly through their smartphones. This approach not only improves access and participation but also significantly boosts statistical power and deepens the understanding of the intricate relationship between patient behavior and trial outcomes. The platform’s capabilities include eCOA (electronic Clinical Outcome Assessment) and ePRO (electronic Patient-Reported Outcome) capture, allowing for flexible configuration of response visibility for sites and sponsors.

Beyond simple pill counts, AiCure’s system proactively anticipates and manages adherence challenges to prevent participant dropouts. Its responsible AI framework integrates diversity from the outset, aiming to eliminate bias in patient engagement. Clinical teams utilizing H.Code have reported considerable reductions in drop-out rates and enhanced streamlining of their research processes, with proven outcomes such as 92% participant retention and over 1.5 million participant doses captured across thousands of clinical trial sites globally.

Breakthrough research conducted by AiCure demonstrates that medication adherence, as captured by H.Code, serves as a reliable marker for participant retention. Early adherence patterns can predict future early termination risk, allowing for proactive interventions. This technology, combined with AiCure’s central monitoring framework (Clinical Site Services), has been shown to reduce early termination rates for adherent participants to just 7.8% across numerous phase I-IV clinical trials.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered computer vision for adherence verification
  • Synchronous chat for participant assistance
  • Predictive analytics for adherence management
  • eCOA and ePRO capture
  • Proactive adherence management to prevent dropouts
  • Responsible AI for bias elimination
  • Central monitoring framework (Clinical Site Services)
  • Support for 45 languages
  • Global deployment across 46 countries

Use Cases

  • Medication adherence monitoring in clinical trials
  • Improving participant retention in clinical studies
  • Gathering real-world evidence for medication adherence
  • Monitoring clinical behavior adherence
  • Proactive management of adherence challenges
  • Enhancing statistical power in clinical trials

What Physicians Need to Know

Real-World Evidence Analysis
AiCure built H.Code, the world's first AI-powered adherence verification platform trusted by pharma, CROs, and providers to verify medication and clinical behavior adherence across the healthcare lifecycle. Data collected using our clinical trial AI platform can be used to support safety and efficacy endpoints while providing a comprehensive view of how therapy impacts participants.
Safety Signal Detection
Breakthrough Research on Early Termination: Our research shows that medication adherence captured through AiCure’s AI-powered platform, H.Code, can serve as a marker for participant retention and that early adherence is predictive of future early termination risk. This technology, coupled with AiCure’s central monitoring framework, Clinical Site Services (CSS), reduced early termination rates for adherent participants to just 7.8% across 28 phase I-IV clinical trials with over 4,000 patients representative of 43 countries.
Collaboration Features
H.Code is designed to be a bridge between your patients and your clinical team. Our unique approach combines cutting-edge patient engagement AI technology with extensive site expertise in one solution, making clinical trials more convenient and accessible for participants and more manageable and effective for clinical sites and study teams.
Publication Support
Resources include Blog, Fact Sheets, Posters, and Publications.
Physician Tip

H.Code, by AiCure, uses AI-powered computer vision, synchronous chat, and predictive analytics to observe and assist trial participants through their smartphone—revolutionizing access and participation, improving statistical power, and deepening our understanding of the relationship between patient behavior and trial outcomes. Clinical teams are using H.Code to enhance and streamline their clinical research processes, with reported benefits including reduced dropout rates and the ability to drive action rather than just passive data collection.

eCOA - ePRO: Capture participant responses and configure response visibility for sites and/or sponsors/CROs as needed.

Details

Category Drug Discovery & Research, Patient Engagement & Education
Pricing Unknown
DeploymentCloud, Mobile
Mobile AppYes
Data Export Yes
Training Yes
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Yes AI-estimated
Integrations
EHR Not specified
Specialties Internal Medicine, Oncology, Psychiatry

Support & Reliability

Training Provided Yes

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AiCure (H. Code)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for AiCure (H. Code).

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

H.Code uses AI-powered computer vision, synchronous chat, and predictive analytics to observe and assist trial participants through their smartphone, streamlining clinical research processes.
H.Code is trusted by pharma, CROs, and providers to verify medication and clinical behavior adherence across the healthcare lifecycle.
H.Code supports a variety of studies for any kind of clinical trial, including traditional site-based, decentralized, fully virtual, or hybrid models.
Data collected using H.Code can be used to support safety and efficacy endpoints while providing a comprehensive view of how therapy impacts participants.
H.Code helps to anticipate and proactively manage medication adherence to prevent dropouts, as adherence is more than just pill counts.

Related Tools

AIRA
AIRA Healthcare
Drug Discovery & Research
AIRA is an AI platform for study design and protocol development, providing expert-level clinical, regulatory, and medical writing AI thought partners to accelerate clinical development workflows.
Biomiv
Cymetica Biosciences
Clinical Decision Support & Reference
Biomiv is an AI health research assistant that provides physicians with insights into health conditions, engineered diets, and live scientific papers and clinical trials.
TrialGPT
National Institutes of Health (NIH)
Drug Discovery & Research
An AI algorithm developed by NIH researchers to speed up the process of matching potential volunteers to relevant clinical research trials listed on ClinicalTrials.gov.
InsightRX
InsightRX
Drug Discovery & Research
InsightRX offers AI-powered precision medicine software for clinical development and point-of-care, combining agentic AI, pharmacometrics, and real-world data to enable smarter, more precise decisions for health systems and life sciences teams.
Indica Labs HALO AI
Indica Labs
Drug Discovery & Research
HALO AI is a deep-learning add-on for the HALO image analysis platform, helping users solve image analysis challenges in segmentation, classification, and phenotyping for research.
Triomics
Triomics
Clinical Decision Support & Reference
Triomics is an AI-powered platform that streamlines clinical trial matching and oncology research by integrating with EHRs to identify eligible cancer patients.

See all Drug Discovery & Research tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-05-13 | First Added: 2026-05-13
AI Tool Finder
AI-powered search. Results may not be comprehensive.